Atlantic Edge Private Wealth Management LLC Buys 140 Shares of Zoetis Inc. (NYSE:ZTS)

Atlantic Edge Private Wealth Management LLC increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 482.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 169 shares of the company’s stock after purchasing an additional 140 shares during the quarter. Atlantic Edge Private Wealth Management LLC’s holdings in Zoetis were worth $28,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Pensionfund Sabic lifted its holdings in Zoetis by 55.6% in the fourth quarter. Pensionfund Sabic now owns 11,200 shares of the company’s stock valued at $1,825,000 after buying an additional 4,000 shares during the period. PFW Advisors LLC acquired a new stake in Zoetis in the fourth quarter worth $1,764,000. JPMorgan Chase & Co. raised its holdings in Zoetis by 10.6% in the third quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company’s stock worth $569,834,000 after purchasing an additional 279,092 shares during the period. Simplify Asset Management Inc. acquired a new stake in Zoetis in the third quarter worth $11,684,000. Finally, Nordea Investment Management AB raised its holdings in Zoetis by 38.3% in the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock worth $336,266,000 after purchasing an additional 572,511 shares during the period. 92.80% of the stock is owned by institutional investors.

Zoetis Trading Up 0.2 %

NYSE:ZTS opened at $171.71 on Tuesday. The firm’s fifty day moving average is $169.26 and its 200-day moving average is $179.21. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The firm has a market cap of $77.47 billion, a P/E ratio of 32.28, a P/E/G ratio of 2.77 and a beta of 0.90.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s dividend payout ratio is currently 37.59%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ZTS shares. Stifel Nicolaus cut their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. UBS Group initiated coverage on shares of Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective on the stock. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, Piper Sandler decreased their target price on shares of Zoetis from $210.00 to $200.00 and set an “overweight” rating for the company in a research report on Monday. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $214.00.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.